VitaNova Life Sciences Corp (VNOV) Revenue (2017 - 2026)
VitaNova Life Sciences (VNOV) posted Revenue of $709625.0 for Q1 2026, up 66.14% quarter-over-quarter from $427115.0 in Q4 2025, and up 130.16% year-on-year from $308318.0 in Q1 2025.
VitaNova Life Sciences Corp (VNOV) Revenue (2017 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has reported Revenue for 7 consecutive years, with $709625.0 the latest figure, recorded in Q1 2026.
- Revenue for Q1 2026 came in at $709625.0, up 130.16% year-over-year; the trailing twelve-month figure through Jan 2026 was $3.2 million (up 154.79% YoY), and the FY2025 annual result was $2.7 million, up 366.47% from the prior year.
- Revenue was $709625.0 for Q1 2026 at VitaNova Life Sciences, up from $427115.0 in the prior quarter.
- Over five years, Revenue peaked at $2.0 million in Q2 2025 and troughed at $3000.0 in Q2 2023.
- Average Revenue over 5 years is $305762.5, with a median of $103899.0 recorded in 2025.
- Year-over-year, Revenue sank 93.33% in 2023 and soared 18053.13% in 2024.
- Over 5 years, Revenue stood at $10000.0 in 2022, then sank by 70.0% to $3000.0 in 2023, then jumped by 9637.27% to $292118.0 in 2024, then soared by 46.21% to $427115.0 in 2025, then surged by 66.14% to $709625.0 in 2026.
- Per Business Quant data, the three most recent Revenue figures were $709625.0 in Q1 2026, $427115.0 in Q4 2025, and $103899.0 in Q3 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 709,625.00 |
| Oct 31, 2025 | 427,115.00 |
| Jul 31, 2025 | 103,899.00 |
| Apr 30, 2025 | 1.95 Mn |
| Jan 31, 2025 | 308,318.00 |
| Oct 31, 2024 | 292,118.00 |
| Jul 31, 2024 | 108,477.00 |
| Apr 30, 2024 | 544,594.00 |
| Jan 31, 2024 | 26,100.00 |
| Apr 30, 2023 | 3,000.00 |
| Jan 31, 2023 | 10,000.00 |
| Oct 31, 2022 | 10,000.00 |
| Jul 31, 2022 | 15,000.00 |
| Apr 30, 2022 | 45,000.00 |
| Jan 31, 2022 | 30,000.00 |
| Oct 31, 2021 | 45,000.00 |
| Jul 31, 2017 | 18,400.00 |